2025
Survival of patients diagnosed with stage IV cancer in 2020 based on COVID-19 status.
Ayoade O, Canavan M, Caturegli G, Zolfaghari E, Resio B, Woodard G, Boffa D. Survival of patients diagnosed with stage IV cancer in 2020 based on COVID-19 status. Journal Of Clinical Oncology 2025, 43 DOI: 10.1200/jco.2025.43.16_suppl.e24041.Peer-Reviewed Original ResearchCancer patient survivalPatient survivalTumor behaviorCOVID-19 infectionCancer typesCharlson-Deyo scoreNational Cancer DatabaseSurvival of patientsKaplan Meier analysisCox proportional hazards modelsStage IV cancerAssociated with lower mortality riskProportional hazards modelCOVID-positive patientsMeier analysisCancer DatabaseLower mortality riskPositive patientsTreatment modalitiesDeyo scoreIV cancerImmune modulationImmunological consequencesCancer patientsYear mortalityUse of broad-spectrum antibiotics in adult cancer patients presenting to emergency department with non-neutropenic fever and/or suspected infection
Li Y, Al Maqrashi Z, Zhan L, Siddiqui Z, Jin E, Ellis P. Use of broad-spectrum antibiotics in adult cancer patients presenting to emergency department with non-neutropenic fever and/or suspected infection. Supportive Care In Cancer 2025, 33: 383. PMID: 40237926, DOI: 10.1007/s00520-025-09419-4.Peer-Reviewed Original ResearchConceptsNon-neutropenic feverBroad-spectrum antibioticsBroad-spectrum intravenous antibioticsBroad-spectrum antibiotic useCancer patientsSuspected infectionAdult cancer patientsAntibiotic useIntravenous antibioticsEmergency departmentAntibiotics prescribed to patientsMethodsA retrospective cohort studySingle-center studyProportion of patientsRetrospective cohort studyStage IV cancerMultivariate logistic regressionImprove antibiotic stewardshipSystemic treatmentSolid malignanciesGenitourinary cancersAdult patientsAntibiotic stewardshipIV cancerCohort study
2024
Trends in breast cancer–specific death by clinical stage at diagnoses between 2000 and 2017
Marczyk M, Kahn A, Silber A, Rosenblit M, Digiovanna M, Lustberg M, Pusztai L. Trends in breast cancer–specific death by clinical stage at diagnoses between 2000 and 2017. Journal Of The National Cancer Institute 2024, 117: 287-295. PMID: 39348186, DOI: 10.1093/jnci/djae241.Peer-Reviewed Original ResearchBreast cancer-specific deathCancer-specific deathBreast cancerStage IAll-Cause MortalityTemporal trendsStage I/II breast cancerHormone receptor-positiveNode-negative cancersPrimary tumor typeStage I/II diseaseMetastatic breast cancerStage II cancerBilateral cancerIV cancerFemale sexIV diseaseReceptor-positiveExcellent prognosisII cancerClinical stageTumor typesTreated patientsStage IIICancer
2012
Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy
Small A, Tsao C, Moshier E, Gartrell B, Wisnivesky J, Godbold J, Smith C, Sonpavde, Oh W, Galsky M. Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy. Cancer 2012, 118: 5947-5954. PMID: 22707387, DOI: 10.1002/cncr.27658.Peer-Reviewed Original ResearchConceptsRate of no treatmentStage IV cancerSolid tumorsAnticancer therapyIV cancerLack of treatmentNational Cancer Data BaseNo treatmentStage IV solid tumorsMetastatic solid tumorsPrevalence ratiosCharacteristics of patientsLog-binomial regression analysisPoor functional statusLack of medical insuranceSystemic therapyProstate cancerMetastatic cancerTreated patientsEstimate prevalence ratiosBlack raceTherapyPatientsCancer typesCancerPrevalence and characteristics of patients with stage IV solid tumors who receive no anticancer therapy.
Small A, Tsao C, Moshier E, Gartrell B, Wisnivesky J, Godbold J, Smith C, Sonpavde G, Oh W, Galsky M. Prevalence and characteristics of patients with stage IV solid tumors who receive no anticancer therapy. Journal Of Clinical Oncology 2012, 30: 6065-6065. DOI: 10.1200/jco.2012.30.15_suppl.6065.Peer-Reviewed Original ResearchStage IV solid tumorsSolid tumorsAnticancer therapyNon-small cell lungNational Cancer DatabaseMetastatic solid tumorsPrevalence ratiosAssociated with increased prevalenceStage IV cancerCharacteristics of patientsLog-binomial regressionPoor functional statusLack of medical insuranceRadiation therapySystemic therapyUntreated patientsCancer DatabaseIV cancerDiagnosis yearEstimate prevalence ratiosStage IVBlack raceTherapyTumorPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply